Package 71610-268-60

Brand: verapamil hydrochloride

Generic: verapamil hydrochloride
NDC Package

Package Facts

Identity

Package NDC 71610-268-60
Digits Only 7161026860
Product NDC 71610-268
Product ID 71610-268_5dfba728-4417-4a75-b194-87feff97aa7b
Description

90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-268-60)

Marketing

Marketing Status
Marketed Since 2019-05-01
Brand verapamil hydrochloride
Generic verapamil hydrochloride
Sample Package No

Linked Drug Pages (1)

verapamil hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "5dfba728-4417-4a75-b194-87feff97aa7b", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897649"], "spl_set_id": ["c635f442-2349-4820-877a-a42e5f0a44b5"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-268-60)", "package_ndc": "71610-268-60", "marketing_start_date": "20190501"}], "brand_name": "verapamil hydrochloride", "product_id": "71610-268_5dfba728-4417-4a75-b194-87feff97aa7b", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "71610-268", "generic_name": "verapamil hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "verapamil hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "240 mg/1"}], "application_number": "ANDA078906", "marketing_category": "ANDA", "marketing_start_date": "20090917", "listing_expiration_date": "20261231"}